Plus   Neg

Mediclinic 2019 Group Results In Line With Market View

Mediclinic International plc (MDC.L) said that its Group results for the 2019 financial year were in line with market expectations in a challenging healthcare environment.

In Switzerland, Hirslanden's performance in the second half of the year was as guided, resulting in a full year EBITDA margin of around 16%.

At the constant currency basis, Group revenue for fiscal year 2019 was up around 3.5% and EBITDA was down around 1.5%.

On a reported basis, annul revenue was up 2.0% from 2.870 billion pounds last year.But, EBITDA declined around 3.5% from 515 million pounds in the previous year.

The company expects adjusted earnings per share to be around 27 pence, compared to 30.0 pence per share paid last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT